Cancer Treatment Market Research Reports & Industry Analysis
Cancer is a disease characterized by uncontrolled cell proliferation. Of the more than 100 types of cancer, lung, breast, and colorectal cancer account for nearly half of new cases per year in the United States. Lung cancer, which is highly correlated with cigarette smoking, is responsible for more deaths than any other form of cancer. Cigarette smoking and other environmental factors are associated with the majority of cancers.
With the growing incidence of cancer, a growing and aging world population and significant medical advances, there will continue to be phenomenal growth in the market for cancer diagnosis and treatment products.
Cancer Treatment Industry Research & Market Reports
-
EGFR Non-Small Cell Lung Cancer (EGFR + NSCLC) - Pipeline Insight, 2024
... drugs in EGFR Non-Small Cell Lung Cancer (EGFR + NSCLC) pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route ... Read More
-
PD-1 and PD-L1 Inhibitors - Competitive landscape, 2024
... covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage PD-1 and PD-L1 Inhibitors: Understanding PD-1 and ... Read More
-
Pancreatic Cancer - Competitive Landscape, 2024
... type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Pancreatic Cancer: Understanding Pancreatic Cancer: Overview Pancreatic cancer is a disease in which ... Read More
-
Immunohistochemistry (IHC) - Market Insights, Competitive Landscape, and Market Forecast- 2030
... Research Institutes, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a respectable CAGR forecast till 2030 owing to the growing instances of infectious diseases and ... Read More
-
Global Circulating Tumor Cells and Cancer Stem Cells Market Growth (Status and Outlook) 2024-2030
... at US$ 14070 million in 2023. With growing demand in downstream market, the Circulating Tumor Cells and Cancer Stem Cells is forecast to a readjusted size of US$ 38710 million by 2030 with a CAGR ... Read More
-
Global Cancer Stem Cell Market 2024 by Company, Regions, Type and Application, Forecast to 2030
... million in 2023 and is forecast to a readjusted size of USD 1777.9 million by 2030 with a CAGR of 7.3% during review period. Cancer stem cells (CSCs) refer to the cells obtained from tumor ... Read More
-
Global Multi-cancer Early Detection Market 2025-2029
... early detection market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market ... Read More
-
Refractory Multiple Myeloma - Global Clinical Trials Review, 2024
... provides top line data relating to the clinical trials on Refractory Multiple Myeloma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage ... Read More
-
Relapsed Multiple Myeloma - Global Clinical Trials Review, 2024
... provides top line data relating to the clinical trials on Relapsed Multiple Myeloma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage ... Read More
-
Burkitt Lymphoma - Global Clinical Trials Review, 2024
... data relating to the clinical trials on Burkitt Lymphoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials ... Read More
-
Viral Vaccines Market Size, Share, Forecast, & Trends Analysis by Form (Liquid, Lyophilized) Type (Live Attenuated, mRNA, Inactivated), Route of Administration (Intramuscular, Subcutaneous, Oral), Approach, Indication, Packaging – Global Forecast to 2031
... Size, Share, Forecast, & Trends Analysis by Form (Liquid, Lyophilized) Type (Live Attenuated, mRNA, Inactivated), Route of Administration (Intramuscular, Subcutaneous, Oral), Approach, Indication, Packaging – Global Forecast to 2031 According to a new market research ... Read More
-
Minimal Residual Disease Testing Market Size, Share, Forecast, & Trends Analysis By Offering, Technology (PCR, Flow Cytometry, NGS) Application (Lymphoma, Leukemia, Multiple Myeloma, Solid Tumor) Sample (Blood, Bone Marrow) – Global Forecast to 2031
... Residual Disease Testing Market Size, Share, Forecast, & Trends Analysis by Offering, Technology (PCR, Flow Cytometry, NGS), Application (Lymphoma, Leukemia, Multiple Myeloma, Solid Tumor), Sample (Blood, Bone Marrow)–Global Forecast to 2031 According to a new ... Read More
-
Global Cancer Stem Cells (CSCs) Market Growth 2024-2030
... downstream market, the Cancer Stem Cells (CSCs) is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the ... Read More
-
2024-2029 Germany Cancer Diagnostics Market Segmentation Analysis: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains - Competitive Analysis, Emerging Technologies, Latest Instrumentation, Growth Opportunities
... of the major business opportunities emerging in the German cancer diagnostics market during the next five years. The report examines trends in the German market; reviews current and emerging assays; analyzes potential applications of new ... Read More
-
2024-2029 France Cancer Diagnostics Market Segmentation Analysis: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains - Competitive Analysis, Emerging Technologies, Latest Instrumentation, Growth Opportunities
... of the major business opportunities emerging in the French cancer diagnostics market during the next five years. The report examines trends in the French market; reviews current and emerging assays; analyzes potential applications of new ... Read More
-
Chemotherapy Market, By Drugs (Alkylating agents, Antimetabolites, Anti-tumor Antibiotics, and Others), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Blood Cancer, Liver Cancer, and Others), By Route of Administration (Oral, Parenteral, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)
... Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa) Chemotherapy is a type of cancer treatment that uses one or ... Read More
-
2024-2029 Europe Cancer Diagnostics Market Segmentation Analysis: France, Germany, Italy, Spain, UK - Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains - Competitive Analysis, Emerging Technologies, Latest Instrumentation, Growth Opportunities
... LeadingMarketResearch.com is based on a study of the major business opportunities emerging in the European cancer diagnostics market during the next five years. The report examines trends in the European market; reviews current and emerging ... Read More
-
2024-2029 Global Cancer Diagnostics Market Segmentation Analysis: US, Europe, Japan - Cancer Clinics, Commercial Labs, Hospitals, Physician Offices - Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains - Competitive Analysis, Emerging Technologies, Latest Instrumentation, Growth Opportunities
... Growth Opportunities This new report from LeadingMarketResearch.com is based on a study of the major business opportunities emerging in the global cancer diagnostics market during the next five years. The report examines trends in the ... Read More
-
2024-2029 Nucleic Acid Testing (NAT) Market: US, Europe, Japan - Supplier Sales and Shares by Test, Volume and Sales Forecasts for 100 Infectious, Cancer and Genetic Diseases, Forensic and Paternity Testing/HLA Typing - Technological Breakthroughs, Emerging Tests, Competitive Analysis
... Emerging Tests, Competitive Analysis This new seven-country study from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular diagnostics market during the next ... Read More
-
Metastatic Lung Adenocarcinoma Treatment Market Size, Share, Trends, Industry Analysis Report: By Treatment (Chemotherapy, Targeted Therapy, Immunotherapy, Radiation Therapy, and Others), End User (Hospitals, Specialty Clinics, and Others), and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2025–2034
... Latin America, and Middle East & Africa) – Market Forecast, 2025–2034 The global metastatic lung adenocarcinoma treatment market size is expected to reach USD 14.17 billion by 2034, according to a new study by Polaris ... Read More
-
2024-2029 France Molecular Genetic, Cancer, Forensic and Paternity Testing Market: Supplier Sales and Shares, Volume and Sales Segment Forecasts, Competitive Analysis, Emerging Technologies, Latest Instrumentation, Growth Opportunities
... help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the next ... Read More
-
2024 Global Cancer Diagnostics Market Players - Market Shares by Country, Strategic Assessments of Major Suppliers and Emerging Market Entrants
... emerging market entrants. The report presents strategic analyses of major current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution tactics, technological know-how, new products in R&D, ... Read More
-
2024 Global Suppliers of Diagnostic Analyzers and Reagents - Strategic Assessments of Major Players and Emerging Market Entrants, SWOT Analysis - Blood Banking, Cancer Diagnostics, Coagulation, Hematology, Immunodiagnostics, Microbiology, Molecular Diagnostics
... LeadingMarketResearch.com provides analyses of 100 major and emerging suppliers of immunodiagnostics, microbiology, cancer diagnostic, molecular diagnostic, hematology, coagulation and blood banking instruments and reagents. The report presents strategic profiles of 100 major and emerging suppliers ... Read More
-
2024-2029 Germany Molecular Genetic, Cancer, Forensic and Paternity Testing Market: Supplier Sales and Shares, Volume and Sales Segment Forecasts, Competitive Analysis, Emerging Technologies, Latest Instrumentation, Growth Opportunities
... help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the next ... Read More
-
2024-2029 Europe Molecular Genetic, Cancer, Forensic and Paternity Testing Market: France, Germany, Italy, Spain, UK - Supplier Sales and Shares, Volume and Sales Segment Forecasts, Competitive Analysis, Emerging Technologies, Latest Instrumentation, Growth Opportunities
... five-country study from VPGMarketResearch is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic ... Read More
Research Assistance
